Is the “1572” Slowing Innovation to Improve Trial Access?
2023-03-10 This week we discussed the Form 1572 and whether or not it is an obstacle to innovative approaches for improving research access for patients. Hosts Craig Lipset, Amir Kalali, and Jane Myles were joined by Shaalan Beg (Science 37) and John Campbell (Walgreens) to discuss.
Follow the Decentralized Trials & Research Alliance (DTRA) on LinkedIn and Twitter. Learn more about Membership and our work at www.dtra.org.
